Biotechnology News

September 24, 2014

TOKYO, Japan & VALBY, Denmark--(BUSINESS WIRE)--US FDA accepts Otsuka and Lundbeck's filing for review of brexpiprazole for the treatment of schizophrenia and as adjunctive therapy for the treatment of major depression

September 24, 2014

PARIS & SAN FRANCISCO--(BUSINESS WIRE)--SpineGuard Releases Six Months 2014 Financial Results

September 24, 2014

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the company has submitted a New Drug Application (NDA) to Japan’s Pharmaceutical and Medical Devices Agency (PMDA) for approval of an investigational...

September 23, 2014

PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company (NASDAQ:MDCO) has scheduled a webcast and conference call of its upcoming Infectious Disease Care Investor & Analyst Day on Wednesday, September 24, 2014, from 9:00 am to 12:00 pm...

September 23, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Tokai Pharmaceuticals Announces Closing of Initial Public Offering

September 23, 2014

NEWTOWN, Pa. & VANCOUVER, British Columbia--(BUSINESS WIRE)--Helius Medical Technologies, Inc. (CSE: HSM) (“HMT”, or the “Company”) announced today that its flagship PoNS™ technology would be tested in a double-blind, randomized, sham-...

September 23, 2014

LAS VEGAS--(BUSINESS WIRE)--Medical Cannabis Payment Solutions (OTC Bulletin Board, REFG), a leader in technological solutions for the medical cannabis industry, today issued an open letter to shareholders. Dear Fellow Shareholders: 2014 has been...

September 23, 2014

PITTSBURGH--(BUSINESS WIRE)--When the body forms new tissues during the healing process, cells must be able to communicate with each other. For years, scientists believed this communication happened primarily through chemical signaling. Now...

September 23, 2014

SUMMIT, N.J.--(BUSINESS WIRE)--Oral OTEZLA (apremilast) Approved by U.S. FDA for Treatment of Patients with Moderate to Severe Plaque Psoriasis

September 23, 2014

BAINBRIDGE, Ga.--(BUSINESS WIRE)--MHG presented their PHA (polyhydroxalkanoates) and PLA (polyactic acid) biopolymers to investors at China’s International Fair for Investment and Trade in Xiamen, China. The event, which signifies huge investment...

September 23, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), today announced that Shai N. Gozani M.D., Ph.D., NeuroMetrix President and Chief Executive Officer, will participate in the 29th Annual Meeting of The Japan Society of Diabetic...

September 23, 2014

STRASBOURG, France--(BUSINESS WIRE)--Regulatory News: Transgene (Paris:TNG) (NYSE-Euronext: TNG) today announced the appointment of Eric Quéméneur, PhD as Executive Vice President in charge of Research and Development. In this position, he will...

September 23, 2014

BENSALEM, Pa.--(BUSINESS WIRE)--BusinessOne Continues Steady Growth: Rebrands, Expands to Better Assist Life Sciences Companies with Data, Technology and Strategic Direction for Increased Market Access.

September 23, 2014

PARIS--(BUSINESS WIRE)--Regulatory News : Cellectis (Paris:ALCLS) : Event Details: Date: October 23, 2014Time: 6:00 to 8:30PMLocation: Cellectis – 11 rue Watt – 75013 Paris André Choulika, PhD, Chairman and Chief Executive Officer of Cellectis,...

September 23, 2014

CHICAGO--(BUSINESS WIRE)--Intellectual Property law firm, Marshall, Gerstein & Borun in Chicago Wins Three Awards at the second annual LMG Life Sciences Awards.

September 23, 2014

SEATTLE--(BUSINESS WIRE)--TapImmune is a clinical-stage immunotherapy company specializing in the development of innovative peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer and infectious disease. The company now...

September 23, 2014

WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) announced today that Scott Tarriff, President and Chief Executive Officer, will present at the 21st Annual BioCentury NewsMakers Conference as follows:       Date...

September 23, 2014

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Tuesday, October 28, 2014. The purpose of the call is to provide an...

September 23, 2014

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Liquidia Technologies today announced it will highlight the rapid antigen and adjuvant formulation capabilities of its PRINT® (Particle Replication In Non-Wetting Templates) technology for the...

September 23, 2014

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Liquidia Technologies today announced it will present an overview of the unique capabilities of its PRINT® (Particle Replication In Non-Wetting Templates) technology at the Nano Manufacturing 2014...

September 23, 2014

REDWOOD CITY, Calif.--(BUSINESS WIRE)--In recognition of its game-changing cloud-based clinical data insights solutions, Comprehend has been named to SVIEF 2014's Top 30 Innovation Awards.

September 23, 2014

LEATHERHEAD, England--(BUSINESS WIRE)--From 30th September-2nd October, the EFIB congress comes to Reims, capital of the beautiful Champagne-Ardenne region; a thriving hub for biobased industries and expertise.Champagne-Ardenne is gearing up to...

September 23, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Hummingbird IRB, an independent institutional review board (IRB), has received full accreditation from the Association for the Accreditation of Human Research Protection Programs, Inc. (AAHRPP).

September 23, 2014

SAN FRANCISCO--(BUSINESS WIRE)--PRC Clinical™ (PRC), a San Francisco Bay Area full-service Contract Research Organization (CRO) specializing in Clinical Trial Management and Monitoring, announced today that Eclipse™ Clinical Payment Services is...

September 23, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--Instrument Business Outlook (IBO) has awarded the Thermo Scientific VersaCool Refrigerated Circulating Bath with the Silver Award for excellence in industrial design for laboratory equipment. The VersaCool...

September 23, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Syros Pharmaceuticals announced today presentation of research at the AACR Hematologic Malignancies Meeting that highlights gene control as an approach to treating cancer.

September 23, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma Inc. (NASDAQ: XLRN), announces results from an interim report evaluating dalantercept as monotherapy in patients with ovarian cancer.

September 23, 2014

PHILADELPHIA--(BUSINESS WIRE)--iCeutica receives key patent for SoluMatrix Fine Particle Technology™ platform by USPTO covering the company’s dry milling method for producing submicron-sized drug particles.

September 23, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences, Inc. (NASDAQ: GNCA), a clinical-stage biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today announced the receipt of a $1.2 million grant from the Bill...

September 23, 2014

PARSIPPANY, N.J.--(BUSINESS WIRE)--As the global market for drugs surpasses $1 trillion this year, growing payer scrutiny of value for money is just one of the factors that will drive disruptive change in the use of medicines over the next decade...

September 23, 2014

LONDON--(BUSINESS WIRE)--MedImmune receives fast track designation from FDA for development of MEDI3902 for prevention of nosocomial pneumonia.

September 23, 2014

WATERTOWN, Mass. & TAMPA, Fla.--(BUSINESS WIRE)--FORMA and Moffitt Cancer Center entered into a research initiative to explore epigenetics and the therapeutic potential of drug candidates targeting HDACs in an open-access business framework...

September 23, 2014

NEW YORK--(BUSINESS WIRE)--Every day, an estimated 6,000 women in the United States reach menopause.1 To inspire this growing population of women and to share her story, Golden Globe® winning actress Kim Cattrall has teamed up with Pfizer Inc. (...

September 23, 2014

BOSTON--(BUSINESS WIRE)--EPIRUS Biopharmaceuticals, Inc. (EPIRUS, NASDAQ:EPRS), a Boston-based biopharmaceutical company focused on the global development and commercialization of biosimilar monoclonal antibodies, today announced positive 58 week...

September 23, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec (NASDAQ:BIIB) has been named the biotechnology industry leader on the Dow Jones Sustainability World Index (DJSI World). The company also was named to the Dow Jones Sustainability Index (DJSI) North...

September 23, 2014

NEW YORK--(BUSINESS WIRE)--Ophthotech Corporation today announced that Michael G. Atieh has been named Executive Vice President, Chief Financial and Business Officer and Treasurer effective September 30, 2014.

September 23, 2014

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea receives Fast Track SBIR grant providing for up to $1.67M from NCI/NIH to fund evaluation of Lymphoseek for sentinel lymph node detection in a clinical study of women with cervical cancer.

September 23, 2014

ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions Inc. (NYSE:EBS) today announced the initiation of the pivotal non-clinical efficacy study to demonstrate that BioThrax® (Anthrax Vaccine Adsorbed) manufactured at large scale in the company’s...

September 23, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec (NASDAQ:BIIB) today announced that Olivier Danos, Ph.D., has joined the company as senior vice president, Gene Therapy. Dr. Danos reports directly to Douglas Williams, Ph.D., executive vice president...

September 23, 2014

KNOXVILLE, Tenn.--(BUSINESS WIRE)--PROVECTUS’ INTRALESIONAL PV-10 AND CO-INHIBITORY BLOCKADE DATA TO BE PRESENTED AT SITC 29TH ANNUAL MEETING Conference to be Held November 6-9, 2014 in National Harbor, MD.

September 23, 2014

MENLO PARK, Calif.--(BUSINESS WIRE)--Credence MedSystems, Inc. announced today the launch of the Credence Companion Safety Syringe System at two upcoming conferences focused on drug delivery solutions. The Companion results from the Credence team...

September 23, 2014

HACKENSACK, N.J.--(BUSINESS WIRE)--In what is likely the broadest deployment in the world of video communications within the research community, the European Organization for Nuclear Research, commonly known as CERN, has reported that its total...

September 23, 2014

BERLIN & BOSTON, Mass.--(BUSINESS WIRE)--NOXXON Spiegelmer receives FDA Orphan Drug Designation for Glioblastoma Treatment

September 23, 2014

CAMBRIDGE, England--(BUSINESS WIRE)--NetScientific (AIM:NSCI), the global biomedical and healthcare technology group today announces its half yearly report for the six months ended 30 June 2014.

September 22, 2014

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix International N.V., (NASDAQ:OFIX), a diversified, global medical device company focused on improving patients’ lives by providing superior reconstructive and regenerative orthopedic and spine solutions...

September 22, 2014

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals, Inc. (NASDAQ: ANAC) today announced the U.S. launch of Anacor’s FDA-approved drug KERYDINTM (tavaborole) topical solution, 5% by Sandoz Inc., a Novartis company. KERYDIN is the first...

September 22, 2014

ANN ARBOR, Mich.--(BUSINESS WIRE)--Esperion Therapeutics, Inc. (NASDAQ: ESPR) a clinical-stage emerging pharmaceutical company focused on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol (LDL-cholesterol)...

September 22, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Xenetic Biosciences, Inc. (OTCBB: XBIO), a biopharmaceutical company focused on developing next-generation biologic drugs and novel oncology therapeutics, today announced that it will hold a business update...

September 22, 2014

BASKING RIDGE, N.J.--(BUSINESS WIRE)--International Headache Meeting Presentation by electroCore - gammaCore therapy reduces cluster headache by 50%